Price Band
₹137 - ₹145
Lot Size
1000
Issue Size
₹69.5 Cr
GMP
N/A
Subscription
300.89x
IPO Schedule
Open
22 Aug 2025
Close
26 Aug 2025
Allotment
28 Aug 2025
Listing
1 Sept 2025
About Anondita Medicare Ltd
Anondita Healthcare Ltd. is an Indian pharmaceutical company focused on manufacturing and marketing a range of pharmaceutical formulations including tablets, capsules, and oral liquids. Their operations are primarily geared towards serving the domestic market with a diverse product portfolio across therapeutic areas.
Key Strengths
- High Return on Equity (ROE) of 41.71% indicates efficient capital utilization and profitability.
- Attractive Price to Earnings (P/E) ratio of 11.74 suggests a potentially undervalued investment opportunity compared to industry peers.
- Established presence in the pharmaceutical formulations market with a diversified product portfolio.
- Focus on the growing domestic pharmaceutical market provides a favorable growth outlook.
- Experience in manufacturing and marketing allows for better control over the value chain.
Risk Factors
- •Being an SME IPO, liquidity in the secondary market may be limited.
- •The pharmaceutical industry is subject to stringent regulations and compliance requirements, potentially impacting profitability.
- •Competition from established players in the pharmaceutical sector could put pressure on market share and pricing.
Valuation Analysis
Considering the company's high ROE and relatively low P/E ratio, the IPO appears reasonably priced within the specified range, offering potential upside for investors. However, investors should carefully consider the inherent risks associated with SME IPOs and the competitive landscape of the pharmaceutical industry.
IPO Details
Key Metrics
Growth & Quality
Subscription
Documents
Registrar
MSPL